| Filed On | Filing |
|---|---|
| 12 Jul 2022 |
Form 3: Jiang Shuling, Director
Holds 7,908,805 shares of Common Stock |
| 31 Mar 2022 |
Form 3: An Chihliang, Chief Financial Officer
Holds 13,334 shares of Common Stock |
| 10 Dec 2021 |
Form 3: Sakamoto Norimi, Director
No securities owned |
| 10 Dec 2021 |
Form 3: Odaira Yoshinobu, Director
Holds 163,702 shares of Common Stock |
| 15 Nov 2021 |
Form 3: Jiang Tsung Shann, Director
Holds 12,103,971 shares of Common Stock |
| 15 Nov 2021 |
Form 3: Miao Shin-Yu, Director
Holds 67,378 shares of Common Stock |
| 15 Nov 2021 |
Form 3: Tseng Shih-Chen, Director
No securities owned |
| 15 Nov 2021 |
Form 3: Jiang Eugene, Director
Holds 732,716 shares of Common Stock |
| 15 Nov 2021 |
Form 3: Jiang Chang-Jen, Director
Holds 5,949 shares of Common Stock |
| 05 Nov 2021 |
Form 3: King Chi-Hsin Richard, Chief Scientific Officer
Holds 869 shares of Common Stock |
| 05 Nov 2021 |
Form 3: Chou Yen-Hsin, Director
Holds 5,679 shares of Common Stock |
| 05 Nov 2021 |
Form 3: Doong Howard, Chief Executive Officer
Holds 18,404 shares of Common Stock |
| 26 Oct 2021 |
Form 3: Jiang Tsang Ming, Director
Holds 6,067 shares of Common Stock |
| 08 Sep 2015 |
Form 3: Lazar Shulamit, Director
Holds 60,000,000 shares of Common Stock |
| 07 Oct 2010 | Form 3: Rempinski Daniel, Director |
| 22 Sep 2010 | Form 3: Orchard James, Director |
| 01 Jul 2010 |
Form 3: Juliano James, Director
Holds 5,200,000 shares of Common Stock |
| 20 May 2010 | Form 3: Iannotti Daniel V, VP, General Counsel & Secretar |
| 22 Sep 2008 | Form 3: DelMonaco, Jr. Rocco, Director |
| 18 Sep 2008 | Form 3: Crockett Robert G, Chief Executive Officer |
Loading...